Partial rescue of defects in Cited2-deficient embryos by HIF-1α heterozygosity

Developmental Biology

Volumn 301, Issue 1, 2007, Pages 130-140

  Xu, Bing ^a   Doughman, Yongqiu ^b   Turakhia, Mona ^a   Jiang, Weihong ^a   Landsettle, Chad E ^a   Agani, Faton H ^a   Semenza, Gregg L ^c   Watanabe, Michiko ^b   Yang, Yu Chung ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c Institute for Cell Engineering   (United States)

Author keywords

Cited2; Heart development; Hypoxia; Vascular endothelial growth factor A

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; PROTEIN; PROTEIN CITED2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONGENITAL BLOOD VESSEL MALFORMATION; CONGENITAL HEART MALFORMATION; CONTROLLED STUDY; EMBRYO; EMBRYO DEATH; EMBRYO DEVELOPMENT; FEMALE; GENE DOSAGE; HEART BLOOD VESSEL; HEART MUSCLE ISCHEMIA; HEART OUTFLOW TRACT OBSTRUCTION; HEART VENTRICLE SEPTUM DEFECT; HETEROZYGOSITY; HYPOXIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; RNA ANALYSIS; SPLEEN DEFECT; WILD TYPE;

EID: 33845724644     PISSN: 00121606     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ydbio.2006.08.072     Document Type: Article

References (36)

1. Bamforth S.D., Braganca J., Eloranta J.J., Murdoch J.N., Marques F.I., Kranc K.R., Farza H., Henderson D.J., Hurst H.C., and Bhattacharya S. Cardiac malformations, adrenal agenesis, neural crest defects and exencephaly in mice lacking Cited2, a new Tfap2 co-activator. Nat. Genet. 29 (2001) 469-474
2. Bamforth S.D., Braganca J., Farthing C.R., Schneider J.E., Broadbent C., Michell A.C., Clarke K., Neubauer S., Norris D., Brown N.A., Anderson R.H., and Bhattacharya S. Cited2 controls left-right patterning and heart development through a Nodal-Pitx2c pathway. Nat. Genet. 36 (2004) 1189-1196
3. Barbera J.P., Rodriguez T.A., Greene N.D., Weninger W.J., Simeone A., Copp A.J., Beddington R.S., and Dunwoodie S. Folic acid prevents exencephaly in Cited2 deficient mice. Hum. Mol. Genet. 11 (2002) 283-293
4. Bhattacharya S., Michels C.L., Leung M.K., Arany Z.P., Kung A.L., and Livingston D.M. Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1. Genes Dev. 13 (1999) 64-75
5. Carmeliet P., and Collen D. Molecular basis of angiogenesis. Role of VEGF and VE-cadherin. Ann. N. Y. Acad. Sci. 902 (2000) 249-264
6. Compernolle V., Brusselmans K., Franco D., Moorman A., Dewerchin M., Collen D., and Carmeliet P. Cardia bifida, defective heart development and abnormal neural crest migration in embryos lacking hypoxia-inducible factor-1 alpha. Cardiovasc. Res. 60 (2003) 569-579
7. Dunwoodie S.L., Rodriguez T.A., and Beddington R.S. Msg1 and Mrg1, founding members of a gene family, show distinct patterns of gene expression during mouse embryogenesis. Mech. Dev. 72 (1998) 27-40
8. Ferrara N., and Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr. Rev. 18 (1997) 4-25
9. Feucht M., Christ B., and Wilting J. VEGF induces cardiovascular malformation and embryonic lethality. Am. J. Pathol. 151 (1997) 1407-1416
10. Franco D., and Campione M. The role of Pitx2 during cardiac development. Linking left-right signaling and congenital heart diseases. Trends Cardiovasc. Med. 13 (2003) 157-163
11. Freedman S.J., Sun Z.Y., Kung A.L., France D.S., Wagner G., and Eck M.J. Structural basis for negative regulation of hypoxia-inducible factor-1alpha by CITED2. Nat. Struct. Biol. 10 (2003) 504-512
12. Huang Y., Hickey R.P., Yeh J.L., Liu D., Dadak A., Young L.H., Johnson R.S., and Giordano F.J. Cardiac myocyte-specific HIF-1alpha deletion alters vascularization, energy availability, calcium flux, and contractility in the normoxic heart. FASEB J. 18 (2004) 1138-1140
13. Hutson M.R., and Kirby M.L. Neural crest and cardiovascular development: a 20-year perspective. Birth Defects Res. C Embryo Today 69 (2003) 2-13
14. Iyer N.V., Kotch L.E., Agani F., Leung S.W., Laughner E., Wenger R.H., Gassmann M., Gearhart J.D., Lawler A.M., Yu A.Y., and Semenza G.L. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev. 12 (1998) 149-162
15. Jain R.K. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307 (2005) 58-62
16. Jiang B.H., Rue E., Wang G.L., Roe R., and Semenza G.L. Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J. Biol. Chem. 271 (1996) 17771-17778
17. Koch C.J. Measurement of absolute oxygen levels in cells and tissues using oxygen sensors and 2-nitroimidazole EF5. Methods Enzymol. 352 (2002) 3-31
18. Licht A.H., Muller-Holtkamp F., Flamme I., and Breier G. Inhibition of hypoxia-inducible factor activity in endothelial cells disrupts embryonic cardiovascular development. Blood 107 (2005) 584-590
19. Liu C., Liu W., Palie J., Lu M.F., Brown N.A., and Martin J.F. Pitx2c patterns anterior myocardium and aortic arch vessels and is required for local cell movement into atrioventricular cushions. Development 129 (2002) 5081-5091
20. Miquerol L., Langille B.L., and Nagy A. Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression. Development 127 (2000) 3941-3946
21. Ryan H.E., Lo J., and Johnson R.S. HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J. 17 (1998) 3005-3015
22. Schlange T., Andree B., Arnold H., and Brand T. Expression analysis of the chicken homologue of CITED2 during early stages of embryonic development. Mech. Dev. 98 (2000) 157-160
23. Semenza G.L. Physiology meets biophysics: visualizing the interaction of hypoxia-inducible factor 1 alpha with p300 and CBP. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 11570-11572
24. Semenza G.L. Angiogenesis in ischemic and neoplastic disorders. Annu. Rev. Med. 54 (2003) 17-28
25. Shai S.Y., Harpf A.E., Babbitt C.J., Jordan M.C., Fishbein M.C., Chen J., Omura M., Leil T.A., Becker K.D., Jiang M., Smith D.J., Cherry S.R., Loftus J.C., and Ross R.S. Cardiac myocyte-specific excision of the β1 integrin gene results in myocardial fibrosis and cardiac failure. Circ. Res. 90 (2002) 458-464
26. Sperling S., Grimm C.H., Dunkel I., Mebus S., Sperling H.P., Ebner A., Galli R., Lehrach H., Fusch C., Berger F., and Hammer S. Identification and functional analysis of CITED2 mutations in patients with congenital heart defects. Hum. Mutat. 26 (2005) 575-582
27. Stoller J.Z., and Epstein J.A. Cardiac neural crest. Semin. Cell Dev. Biol. 16 (2005) 704-715
28. Sugishita Y., Watanabe M., and Fisher S.A. Role of myocardial hypoxia in the remodeling of the embryonic avian cardiac outflow tract. Dev. Biol. 267 (2004) 294-308
29. Sugishita Y., Leifer D.W., Watanabe M., Agani F.H., and Fisher S.A. Hypoxia-responsive signaling regulates the apoptosis-dependent remodeling of the embryonic avian cardiac outflow tract. Dev. Biol. 273 (2004) 285-296
30. Sun H.B., Zhu Y.X., Yin T., Sledge G., and Yang Y.C. MRG1, the product of a melanocyte-specific gene related gene, is a cytokine-inducible transcription factor with transformation activity. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 13555-13560
31. Sundberg C., Nagy J.A., Brown L.F., Feng D., Eckelhoefer I.A., Manseau E.J., Dvorak A.M., and Dvorak H.F. Glomeruloid microvascular proliferation follows adenoviral vascular permeability factor/vascular endothelial growth factor-164 gene delivery. Am. J. Pathol. 158 (2001) 1145-1160
32. Thurston G., Suri C., Smith K., McClain J., Sato T.N., Yancopoulos G.D., and McDonald D.M. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 286 (1999) 2511-2514
33. Weninger W.J., Floro K.L., Bennett M.B., Withington S.L., Preis J.I., Barbera J.P., Mohun T.J., and Dunwoodie S.L. Cited2 is required both for heart morphogenesis and establishment of the left-right axis in mouse development. Development 132 (2005) 1337-1348
34. Wikenheiser J., Doughman Y.Q., Fisher S.A., and Watanabe M. Differential levels of tissue hypoxia in the developing chicken heart. Dev. Dyn. 235 (2006) 115-123
35. Yin Z., Haynie J., Yang X., Han B., Kiatchoosakun S., Restivo J., Yuan S., Prabhakar N.R., Herrup K., Conlon R.A., Hoit B.D., Watanabe M., and Yang Y.C. The essential role of Cited2, a negative regulator for HIF-1alpha, in heart development and neurulation. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 10488-10493
36. Yokota H., Goldring M.B., and Sun H.B. CITED2-mediated regulation of MMP-1 and MMP-13 in human chondrocytes under flow shear. J. Biol. Chem. 278 (2003) 47275-47280